ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $41,717,000 | +6.1% | 36,592,000 | +10.6% | 0.53% | +2.9% |
| Q2 2019 | $39,313,000 | -54.3% | 33,092,000 | -48.0% | 0.51% | -56.2% |
| Q1 2019 | $85,986,000 | +31.0% | 63,592,000 | +4.3% | 1.17% | +48.9% |
| Q4 2018 | $65,620,000 | +3.0% | 60,952,000 | +0.7% | 0.79% | +6.3% |
| Q3 2018 | $63,711,000 | +3.1% | 60,510,000 | -4.0% | 0.74% | -7.4% |
| Q2 2018 | $61,788,000 | +45.9% | 63,010,000 | +47.8% | 0.80% | +46.0% |
| Q1 2018 | $42,343,000 | -27.2% | 42,644,000 | -22.5% | 0.55% | -6.8% |
| Q4 2017 | $58,140,000 | -42.8% | 55,044,000 | -42.8% | 0.59% | -47.8% |
| Q3 2017 | $101,731,000 | -0.2% | 96,239,000 | 0.0% | 1.13% | -12.9% |
| Q2 2017 | $101,898,000 | +9.9% | 96,239,000 | 0.0% | 1.29% | -10.1% |
| Q1 2017 | $92,708,000 | -16.7% | 96,239,000 | -12.3% | 1.44% | 0.0% |
| Q4 2016 | $111,321,000 | +1460.2% | 109,739,000 | +997.4% | 1.44% | +1232.4% |
| Q2 2016 | $7,135,000 | -79.4% | 10,000,000 | -73.6% | 0.11% | -89.0% |
| Q1 2016 | $34,658,000 | -19.5% | 37,810,000 | -0.9% | 0.98% | +6.3% |
| Q4 2015 | $43,057,000 | – | 38,160,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|